Sanofi (Sanofi) Cash Flow for Dividends

: $0 Mil (TTM As of Jun. 2023)

View and export this data going back to 2002. Start your Free Trial

Sanofi's cash flow for dividends for the six months ended in Jun. 2023 was $0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Jun. 2023 was $0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Sanofi's quarterly payment of dividends declined from Jun. 2022 ($-4,406 Mil) to Dec. 2022 ($0 Mil) but then stayed the same from Dec. 2022 ($0 Mil) to Jun. 2023 ($0 Mil).

Sanofi's annual payment of dividends declined from Dec. 2021 ($-4,529 Mil) to Dec. 2022 ($-4,415 Mil) but then increased from Dec. 2022 ($-4,415 Mil) to Dec. 2023 ($-4,857 Mil).

Sanofi Cash Flow for Dividends Historical Data

The historical data trend for Sanofi's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow for Dividends

Get a 7-Day Free Trial

-4,260.00

-4,789.54

-4,528.81

-4,415.25

-4,857.14

Sanofi Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash Flow for Dividends	Get a 7-Day Free Trial															-	-4,405.92	-	-	-

Sanofi Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0 Mil.

Sanofi Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Sanofi's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Sanofi (Sanofi) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (NAS:SNY) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

SNYNF:USA SNY:Mexico SANF:Italy 0A2V:UK SANp:UK 0O59:UK SAN:France SNW:Germany SNW2:Germany SNW:Germany SNW:Germany SNW2:Germany SNW:Germany SANO:Austria

Address

46, avenue de la Grande Armée, Paris, FRA, 75017

Website

https://www.sanofi.com

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 15% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.